Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 4686189, 6 pages
http://dx.doi.org/10.1155/2016/4686189
Research Article

Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer

1Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
2School of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
3Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
4Tabriz Health Services Management Research Center and Department of Statistics and Epidemiology, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
5Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
6Common Diseases Risk Factors Management Institute, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran

Received 30 August 2015; Accepted 24 December 2015

Academic Editor: Helieh Oz

Copyright © 2016 Ali Esfahani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. C. Crumley, D. C. McMillan, M. McKernan, A. C. McDonald, and R. C. Stuart, “Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer,” British Journal of Cancer, vol. 94, no. 5, pp. 637–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Chau, A. R. Norman, D. Cunningham, J. S. Waters, J. Oates, and P. J. Ross, “Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data,” Journal of Clinical Oncology, vol. 22, no. 12, pp. 2395–2403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Ando, Y. Ando, Y. Hasegawa et al., “Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer,” British Journal of Cancer, vol. 85, no. 11, pp. 1634–1639, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. McMillan, “Systemic inflammation, nutritional status and survival in patients with cancer,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 12, no. 3, pp. 223–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bauer, S. Capra, and M. Ferguson, “Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer,” European Journal of Clinical Nutrition, vol. 56, no. 8, pp. 779–785, 2002. View at Google Scholar
  6. A. B. C. Crumley, D. C. McMillan, M. McKernan, J. J. Going, C. J. Shearer, and R. C. Stuart, “An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer,” British Journal of Cancer, vol. 94, no. 11, pp. 1568–1571, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. S. D. Roxburgh and D. C. McMillan, “Role of systemic inflammatory response in predicting survival in patients with primary operable cancer,” Future Oncology, vol. 6, no. 1, pp. 149–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. C. McMillan, “An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer,” Proceedings of the Nutrition Society, vol. 67, no. 3, pp. 257–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Proctor, D. S. Morrison, D. Talwar et al., “An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study,” British Journal of Cancer, vol. 104, no. 4, pp. 726–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ikeya, M. Shibutani, K. Maeda et al., “Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 2, pp. 307–313, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Byström, Å. Berglund, P. Nygren et al., “Evaluation of predictive markers for patients with advanced colorectal cancer,” Acta Oncologica, vol. 51, no. 7, pp. 849–859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Kelly, F. Paulin, D. Lamont et al., “Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer,” British Journal of Cancer, vol. 106, no. 5, pp. 955–961, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-G. Mahlck and K. Granvist, “Plasma prealbumin in women with epithelial ovarian carcinoma,” Gynecologic and Obstetric Investigation, vol. 37, no. 2, pp. 135–140, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Alifano, A. Mansuet-Lupo, F. Lococo et al., “Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer,” PLoS ONE, vol. 9, no. 9, Article ID e106914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kawai and H. Ota, “Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer,” World Journal of Surgery, vol. 36, no. 12, pp. 2853–2857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Esfahani, Z. Ghoreishi, M. Abedi Miran et al., “Nutritional assessment of patients with acute leukemia during induction chemotherapy: association with hospital outcomes,” Leukemia & Lymphoma, vol. 55, no. 8, pp. 1743–1750, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Read, S. T. B. Choy, P. Beale, and S. J. Clarke, “An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic,” Asia-Pacific Journal of Clinical Oncology, vol. 2, no. 2, pp. 80–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-Y. Ho, H.-R. Guo, H. H. W. Chen, and C.-J. Peng, “Nutritional predictors of survival in terminally ill cancer patients,” Journal of the Formosan Medical Association, vol. 102, no. 8, pp. 544–550, 2003. View at Google Scholar · View at Scopus
  19. Y. Inoue, R. Nezu, H. Matsuda, Y. Takagi, and A. Okada, “Rapid turnover proteins as a prognostic indicator in cancer patients,” Surgery Today, vol. 25, no. 6, pp. 498–506, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. F. K. Beck and T. C. Rosenthal, “Prealbumin: a marker for nutritional evaluation,” American Family Physician, vol. 65, no. 8, pp. 1575–1578, 2002. View at Google Scholar · View at Scopus
  21. G. Devoto, F. Gallo, C. Marchello et al., “Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients,” Clinical Chemistry, vol. 52, no. 12, pp. 2281–2285, 2006. View at Publisher · View at Google Scholar · View at Scopus